fluconazole has been researched along with Acquired Immune Deficiency Syndrome in 217 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study has been to evaluate the role, therapeutic efficacy, and the cost-benefit ratio of two antifungal drugs, fluconazole and flucytosine, compared with a placebo, in the treatment of endoscopically-diagnosed esophageal candidiasis in patients with acquired immune deficiency syndrome (AIDS)." | 9.08 | Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "The aim of this study was to assess the role and therapeutic efficacy of two azole antifungal drugs, fluconazole and itraconazole, in the treatment of endoscopically-diagnosed Candida oesophagitis in patients with Acquired Immunodeficiency Syndrome (AIDS)." | 9.08 | Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. ( Barbaro, G; Di Lorenzo, G, 1995) |
| "To determine the clinical and endoscopic response of candida esophagitis to antifungal therapy and to compare the two oral antifungal agents, fluconazole and ketoconazole." | 9.07 | Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. ( Conteas, CN; Dretler, RH; Islam, MZ; Koster, FM; Laine, L; Sattler, F; Squires, K; Tuazon, C, 1992) |
| "In order to evaluate the efficacy of 200 mg single weekly dose of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS, 18 patients who had an endoscopic confirmation of cure after an esophageal candidiasis, were studied." | 9.07 | [Secondary prevention of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome]. ( García Puig, J; Gil, A; Khamashta, M; Lavilla Uriol, P; López Dupla, M; Ortiz Vázquez, J; Pintado, V; Valencia, E, 1992) |
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 9.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| "The efficacy and safety of fluconazole in the treatment of oesophageal candidiasis in patients with the acquired immunodeficiency syndrome (AIDS) was assessed in 36 patients." | 9.07 | Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS. ( Dupla, ML; García-Puig, J; Gil, A; Khamashta, MA; Lavilla, P; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1991) |
| "To compare the efficacy of fluconazole with amphotericin B plus flucytosine in the treatment of cryptococcal meningitis." | 9.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| "Fluconazole 50 mg daily for 14-28 days was effective in the treatment of patients with AIDS and AIDS-related complex with severe oropharyngeal and oesophageal candidiasis." | 9.06 | Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. ( Dunbar, EM; Ellis, ME; Leen, CL; Mandal, BK, 1990) |
| " After administration of amphotericin B for acute disseminated cryptococcosis, and prior to initiation of fluconazole therapy, Cryptococcus neoformans was isolated from the cerebrospinal fluid (CSF) in two patients and from the blood in one patient." | 9.06 | Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. ( Saunders, C; Sugar, AM, 1988) |
| " We present possibly the first reported case of Candida infection of the epiglottis in an adult with human immunodeficiency virus treated with oral fluconazole." | 8.79 | Candida epiglottitis in an adult with acquired immunodeficiency syndrome treated with oral fluconazole. ( Israel, L; Sadigh, M, 1995) |
| "Fluconazole is a novel triazole antifungal drug chiefly used in the treatment of opportunistic mycoses in immuno-compromised patients, particularly those with the acquired immuno-deficiency syndrome (AIDS)." | 8.78 | Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections. ( Lafaix, C; Patey, ON; Vincent-Ballereau, FN, 1991) |
| "In sequential clinical trials of treatment for histoplasmosis in patients with acquired immunodeficiency syndrome, therapy with fluconazole failed in a higher proportion of patients than did therapy with itraconazole." | 7.71 | Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. ( Brizendine, E; Connolly, P; Hafner, R; Smedema, M; Wheat, LJ, 2001) |
| "Although fluconazole is increasingly utilized for the therapy of Candida oesophagitis in patients with AIDS, the time course of response has not been adequately defined." | 7.69 | Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS. ( Wilcox, CM, 1994) |
| " Cryptococcal meningitis is a common life-threatening infection in AIDS patients, usually treated with amphotericin B, often in combination with flucytosine." | 7.68 | Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. ( Buxton, MJ; Dubois, DJ; Robinson, PA; Sculpher, MJ; Searcy, C; Turner, RR, 1991) |
| "The detailed pharmacokinetics of fluconazole in serum and cerebrospinal fluid (CSF) were studied in a patient with acquired immunodeficiency syndrome and cryptococcal meningitis, after an intravenous dose of 400 mg." | 7.68 | Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis. ( Chin, T; Fong, IW; Vandenbroucke, A, 1990) |
| "Twenty-two patients with AIDS and various forms of cryptococcosis were treated in an open-label study with 50 to 400 mg/day of fluconazole." | 7.67 | Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. ( Graybill, JR; Hartman, BJ; Murray, HW; Rowland, V; Sharkey, P; Squires, KE; Stern, JJ, 1988) |
| "After primary treatment for cryptococcal meningitis, patients with the acquired immunodeficiency syndrome (AIDS) require some form of continued suppressive therapy to prevent relapse." | 6.67 | A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. ( Cloud, GA; Follansbee, SE; Graybill, JR; Jacobson, JM; McAuliffe, VJ; Meyer, RD; Powderly, WG; Robinson, P; Saag, MS; Sugar, AM, 1992) |
| "In patients with the acquired immunodeficiency syndrome (AIDS), the rate of relapse after primary treatment for cryptococcal meningitis remains high." | 6.67 | A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. ( Bozzette, SA; Chiu, J; Gilbert, G; Jacobsen, J; Larsen, RA; Leal, MA; McCutchan, JA; Robinson, P; Rothman, P; Tilles, J, 1991) |
| "Fluconazole is a triazole antifungal agent which is now an established part of therapy in patients with immune deficiencies." | 6.39 | Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients. ( Barradell, LB; Goa, KL, 1995) |
| "In separate trials in patients with AIDS, clinical response was similar with itraconazole (85%) and fluconazole (74%)." | 5.31 | Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS. ( Brizendine, E; Connolly, P; Haddad, N; Hafner, R; Le Monte, A; Wheat, LJ, 2002) |
| "Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) is particularly common in tropical Africa." | 5.28 | Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatment with fluconazole. ( Aubry, P; Bogaerts, J; Dupont, B; Durbec, JP; Kadio, A; Laroche, R; Latif, A; M'Pele, P; Taelman, H; Touze, JE, 1992) |
| "Fluconazole was well tolerated in all the patients." | 5.28 | [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes]. ( García Puig, J; Gil, A; Khamashta, M; Lavilla, P; López Dupla, M; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1992) |
| " The aim of this study has been to evaluate the role, therapeutic efficacy, and the cost-benefit ratio of two antifungal drugs, fluconazole and flucytosine, compared with a placebo, in the treatment of endoscopically-diagnosed esophageal candidiasis in patients with acquired immune deficiency syndrome (AIDS)." | 5.08 | Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "The aim of this study was to assess the role and therapeutic efficacy of two azole antifungal drugs, fluconazole and itraconazole, in the treatment of endoscopically-diagnosed Candida oesophagitis in patients with Acquired Immunodeficiency Syndrome (AIDS)." | 5.08 | Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. ( Barbaro, G; Di Lorenzo, G, 1995) |
| "The purpose of this prospective, open-label, noncomparative, multicentre study was to evaluate the efficacy and safety of fluconazole in the treatment of hospitalised patients with mycoses." | 5.08 | Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections. Multicentre European Study Group. ( Troke, PF, 1997) |
| "To determine the clinical and endoscopic response of candida esophagitis to antifungal therapy and to compare the two oral antifungal agents, fluconazole and ketoconazole." | 5.07 | Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. ( Conteas, CN; Dretler, RH; Islam, MZ; Koster, FM; Laine, L; Sattler, F; Squires, K; Tuazon, C, 1992) |
| "The recently developed antifungal agents itraconazole and fluconazole have been evaluated for primary and maintenance therapy for mycoses in patients with acquired immune deficiency syndrome (AIDS) in comparative and non-comparative trials." | 5.07 | Opportunistic fungal infections in patients with acquired immune deficiency syndrome. ( Viviani, MA, 1992) |
| "In order to evaluate the efficacy of 200 mg single weekly dose of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS, 18 patients who had an endoscopic confirmation of cure after an esophageal candidiasis, were studied." | 5.07 | [Secondary prevention of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome]. ( García Puig, J; Gil, A; Khamashta, M; Lavilla Uriol, P; López Dupla, M; Ortiz Vázquez, J; Pintado, V; Valencia, E, 1992) |
| "Intravenous amphotericin B, with or without flucytosine, is usually standard therapy for cryptococcal meningitis in patients with the acquired immunodeficiency syndrome (AIDS)." | 5.07 | Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. ( Cloud, GA; Fisher, JF; Grieco, MH; Powderly, WG; Robinson, P; Saag, MS; Sharkey, PK; Sugar, AM; Thompson, SE; Tuazon, CU, 1992) |
| "To assess the efficacy and tolerance of fluconazole in the treatment of oesophageal candidiasis, 47 AIDS patients with this infection were enrolled in an open prospective study using fluconazole 100 mg given orally once daily." | 5.07 | Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. ( Clumeck, N; De Wit, S; Rahir, F; Urbain, D; Weerts, D, 1991) |
| "The efficacy and safety of fluconazole in the treatment of oesophageal candidiasis in patients with the acquired immunodeficiency syndrome (AIDS) was assessed in 36 patients." | 5.07 | Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS. ( Dupla, ML; García-Puig, J; Gil, A; Khamashta, MA; Lavilla, P; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1991) |
| "To compare the efficacy of fluconazole with amphotericin B plus flucytosine in the treatment of cryptococcal meningitis." | 5.06 | Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. ( Chan, LS; Larsen, RA; Leal, MA, 1990) |
| "Fluconazole 50 mg daily for 14-28 days was effective in the treatment of patients with AIDS and AIDS-related complex with severe oropharyngeal and oesophageal candidiasis." | 5.06 | Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. ( Dunbar, EM; Ellis, ME; Leen, CL; Mandal, BK, 1990) |
| "In a randomised, double-blind study the efficacy and toxicity of oral fluconazole 50 mg daily and ketoconazole 200 mg daily were compared for the treatment of oropharyngeal candidiasis in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC)." | 5.06 | Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. ( Clumeck, N; De Wit, S; Goossens, H; Weerts, D, 1989) |
| " After administration of amphotericin B for acute disseminated cryptococcosis, and prior to initiation of fluconazole therapy, Cryptococcus neoformans was isolated from the cerebrospinal fluid (CSF) in two patients and from the blood in one patient." | 5.06 | Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. ( Saunders, C; Sugar, AM, 1988) |
| " We present possibly the first reported case of Candida infection of the epiglottis in an adult with human immunodeficiency virus treated with oral fluconazole." | 4.79 | Candida epiglottitis in an adult with acquired immunodeficiency syndrome treated with oral fluconazole. ( Israel, L; Sadigh, M, 1995) |
| "Fluconazole is a novel triazole antifungal drug chiefly used in the treatment of opportunistic mycoses in immuno-compromised patients, particularly those with the acquired immuno-deficiency syndrome (AIDS)." | 4.78 | Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections. ( Lafaix, C; Patey, ON; Vincent-Ballereau, FN, 1991) |
| "These findings support careful monitoring for relapse in patients receiving voriconazole treatment for histoplasmosis, particularly in those who were previously treated with fluconazole." | 3.73 | Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole. ( Brizendine, E; Connolly, P; Durkin, M; Goldman, M; Mann, P; McNicholas, PM; Patel, R; Smedema, M; Wheat, LJ, 2006) |
| "In sequential clinical trials of treatment for histoplasmosis in patients with acquired immunodeficiency syndrome, therapy with fluconazole failed in a higher proportion of patients than did therapy with itraconazole." | 3.71 | Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. ( Brizendine, E; Connolly, P; Hafner, R; Smedema, M; Wheat, LJ, 2001) |
| "Although fluconazole is increasingly utilized for the therapy of Candida oesophagitis in patients with AIDS, the time course of response has not been adequately defined." | 3.69 | Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS. ( Wilcox, CM, 1994) |
| " Cryptococcal meningitis is a common life-threatening infection in AIDS patients, usually treated with amphotericin B, often in combination with flucytosine." | 3.68 | Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. ( Buxton, MJ; Dubois, DJ; Robinson, PA; Sculpher, MJ; Searcy, C; Turner, RR, 1991) |
| "We describe a patient with the acquired immunodeficiency syndrome who had persistent oral esophageal pseudomembranous candidiasis clinically refractory to nystatin, clotrimazole, and ketoconazole." | 3.68 | Treatment of refractory oral candidiasis with fluconazole. A case report. ( Chafey, S; Franker, C; Hardy, WD; Lucatorto, FM, 1991) |
| "Fluconazole, a novel triazole antifungal drug, holds promise as a significant advance in the management of human fungal diseases." | 3.68 | Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients. ( Cavanna, C; Gramegna, G; Lombardi, G; Michelone, G, 1990) |
| "The detailed pharmacokinetics of fluconazole in serum and cerebrospinal fluid (CSF) were studied in a patient with acquired immunodeficiency syndrome and cryptococcal meningitis, after an intravenous dose of 400 mg." | 3.68 | Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis. ( Chin, T; Fong, IW; Vandenbroucke, A, 1990) |
| "Clinical evaluation of fluconazole was performed on 12 cases of mycotic infections (7 cases of Candida esophagitis; one each case of cryptococcal meningitis with AIDS, Candida tropicalis fungemia and disseminated cryptococcosis in kidney transplant patient; 2 cases of Candida pneumonia)." | 3.67 | [Clinical evaluation of fluconazole]. ( Goto, H; Goto, M; Mori, H; Nakata, H; Oka, S; Shimada, K; Tokitsu, M, 1989) |
| "20 patients (18 men, 2 women), 10 of whom were HIV +, were given Fluconazole (F) for either systemic candidiasis (13 cases), histoplasmosis (1), or cryptococcosis (6)." | 3.67 | [Value of fluconazole in the treatment of systemic yeast infection]. ( Bernard, E; Carles, M; Dellamonica, P; Fournier, JP; Toussaint-Gari, M, 1989) |
| "Twenty-two patients with AIDS and various forms of cryptococcosis were treated in an open-label study with 50 to 400 mg/day of fluconazole." | 3.67 | Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. ( Graybill, JR; Hartman, BJ; Murray, HW; Rowland, V; Sharkey, P; Squires, KE; Stern, JJ, 1988) |
| " With the exception of a higher incidence of gastrointestinal side effects in the 2000mg cohort, both induction doses of FCZ were safe and well tolerated." | 3.30 | Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS ( Aberg, JA; Badal-Faesen, S; Bukuru, A; Clifford, DB; Hogg, E; Komarow, L; Lagat, D; Lalloo, UG; Langat, D; Larsen, RA; Mave, V; McKhann, A; Pillay, S; Samaneka, W; Supparatpinyo, K; Ticona, E, 2023) |
| "Amphotericin B treatment in cryptococcosis requires daily hospital visits or admission." | 2.72 | Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients. ( Boonpokbn, L; Maek-a-Nantawat, W; Mctm, AG; Phonrat, B; Pitisuttithum, P; Tansuphaswadikul, S, 2006) |
| "Cryptococcal meningitis is one of the major complications affecting the central nervous system of patients suffering from AIDS." | 2.71 | The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients. ( Anunnatsiri, S; Chetchotisakd, P; Choksawadphinyo, K; Mootsikapun, P, 2003) |
| " Blood samples were collected from the first 12 patients in each group and pharmacokinetic parameters for fluconazole were calculated." | 2.71 | Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS. ( Panomvana Na Ayudhya, D; Tansuphaswadikul, S; Thanompuangseree, N, 2004) |
| "The test is applied on AIDS prophylaxis and paediatric trials." | 2.69 | Combining mortality and longitudinal measures in clinical trials. ( Finkelstein, DM; Schoenfeld, DA, 1999) |
| "Fluconazole (FCZ) has been extensively used as a primary therapy for oropharyngeal candidosis in AIDS patients." | 2.68 | Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole. ( Dromer, F; Dupont, B; Garcia-Hermoso, D; Improvisi, L; Provost, F, 1995) |
| " studies were modelled simultaneously by iterative two-stage analysis, which provided individual parameter estimates and a population pharmacokinetic model." | 2.67 | Pharmacokinetics and bioavailability of fluconazole in patients with AIDS. ( Cohen, LG; DeMuria, D; Forrest, A; Kazanjian, PH; Rich, J; Scavone, JM, 1993) |
| "After primary treatment for cryptococcal meningitis, patients with the acquired immunodeficiency syndrome (AIDS) require some form of continued suppressive therapy to prevent relapse." | 2.67 | A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. ( Cloud, GA; Follansbee, SE; Graybill, JR; Jacobson, JM; McAuliffe, VJ; Meyer, RD; Powderly, WG; Robinson, P; Saag, MS; Sugar, AM, 1992) |
| " In group 2, on 57 of 3316 days (2%), fluconazole in a higher dosage was administered for treatment." | 2.67 | Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. ( Gentschew, G; Helm, EB; Just-Nübling, G; Meissner, K; Odewald, J; Staszewski, S; Stille, W, 1991) |
| "In patients with the acquired immunodeficiency syndrome (AIDS), the rate of relapse after primary treatment for cryptococcal meningitis remains high." | 2.67 | A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. ( Bozzette, SA; Chiu, J; Gilbert, G; Jacobsen, J; Larsen, RA; Leal, MA; McCutchan, JA; Robinson, P; Rothman, P; Tilles, J, 1991) |
| "Fluconazole-treated patients were more likely to remain disease free during follow-up than those treated with clotrimazole (P = 0." | 2.67 | Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. ( Fass, RJ; Koletar, SL; Plouffe, JF; Russell, JA, 1990) |
| "Amphotericin B was started thereafter but discontinued three days later in favor of fluconazole 400 mg/d due to worsening renal function." | 2.61 | Clinical diversity of invasive cryptococcosis in AIDS patients from central China: report of two cases with review of literature. ( Cao, Q; Cooper, B; Gui, X; Sherer, R; Zhang, Y, 2019) |
| "For persons with symptomatic cryptococcal meningitis, optimal initial management with amphotericin and flucytosine improves survival compared to alternative therapies; however, amphotsericin is difficult to administer and flucytosine has not been available in middle or low income countries, where cryptococcal meningitis is most prevalent." | 2.55 | Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings. ( Abassi, M; Boulware, DR; Lofgren, S; Rhein, J, 2017) |
| "The IRIS presentation was lymphadenitis in all three patients; one patient also had meningeal IRIS." | 2.43 | Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature. ( Hardy, RD; Hester, LJ; Skiest, DJ, 2005) |
| "Short-duration therapy of most dermatophyte infections is also possible with itraconazole." | 2.39 | Current therapy of dermatophytosis. ( DeDoncker, PR; Degreef, HJ, 1994) |
| "In patients with AIDS with cryptococcosis, prompt diagnosis is essential." | 2.39 | Management of systemic manifestations of fungal disease in patients with AIDS. ( Stevens, DA, 1994) |
| "Fluconazole is a triazole antifungal agent which is now an established part of therapy in patients with immune deficiencies." | 2.39 | Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients. ( Barradell, LB; Goa, KL, 1995) |
| "Treatment of cryptococcal meningitis in patients with AIDS with amphotericin B plus flucytosine is associated with a failure rate of 20%-30%." | 2.38 | Therapy for cryptococcal meningitis in patients with AIDS. ( Powderly, WG, 1992) |
| "The authors report a case of AIDS revealed by pleuropulmonary cryptococcosis." | 2.38 | [Pleuropulmonary cryptococcosis disclosing AIDS]. ( Akoun, G; Denis, M; Lechapt, E; Mayaud, C; Milleron, B; Zalcman, G, 1991) |
| "Cryptococcosis is currently the most common life threatening mycoses found in patients with the acquired immunodeficiency syndrome (AIDS)." | 2.38 | Overview: cryptococcosis in the patient with AIDS. ( Sugar, AM, 1991) |
| "Cryptococcosis is the most common life-threatening mycosis with AIDS." | 2.38 | [Cryptococcosis in AIDS: therapeutic concepts]. ( Ruf, B, 1990) |
| "I have tried to use the AIDS commentaries to keep up with these advances." | 2.38 | Azoles and AIDS. ( Larsen, RA, 1990) |
| "Invasive fungal infections are major problems in immunocompromised patients and optimal therapeutical modalities are still far from optimal." | 2.38 | [Current progress in antifungal therapy: the value of fluconazole]. ( Meunier, F, 1990) |
| "Systemic fungal infections are life-threatening diseases that are occurring with increasing frequency, especially in immunocompromised patients." | 2.37 | Recent advances in the treatment of systemic fungal infections. ( Walsh, TJ, 1987) |
| " Although there was a 40% increase in the volume of distribution for fluconazole relative to healthy volunteers, the pharmacodynamic targets for prophylaxis were still met." | 1.62 | Pharmacokinetics of fluconazole and ganciclovir as combination antimicrobial chemotherapy on ECMO: a case report. ( Abdul-Aziz, MH; Dhanani, JA; Lipman, J; Livermore, A; Pincus, J; Roberts, JA; Townsend, S; Wallis, SC, 2021) |
| "He had multiple prior episodes of cryptococcal meningitis with complications necessitating ventriculoperitoneal shunt placement and was on suppressive fluconazole when he developed worsening brain manifestations." | 1.56 | Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient. ( Jeng, A; Kalinoski, T; Malenfant, J; Yim, C, 2020) |
| "Cryptococcal meningitis has a high morbidity and mortality among AIDS population." | 1.51 | Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil. ( Borges, MASB; de Araújo Filho, JA; de Bastos, AL; de Paula, VV; Moreira, IS; Oliveira, BJS; Soares, RBA; Turchi, MD, 2019) |
| "Cryptococcal meningitis is one of the leading causes of death in HIV/AIDS patients." | 1.46 | Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain. ( Alastruey-Izquierdo, A; Aller, AI; Cuesta, I; Gago, S; Gómez-López, A; Martín-Mazuelos, E; Mellado, E; Serrano, C, 2017) |
| "The treatment with fluconazole and ARV led to a favorable outcome." | 1.40 | [Non-neuromeningeal cryptococcosis in patients with AIDS in Bamako, Mali: 2 case reports]. ( Chabasse, D; Coulibaly, I; Dembélé, M; Diallo, K; Dolo, A; Kamaté, B; Minta, DK; Ouologuem, DS; Pichard, E; Soukho-Kaya, A; Traoré, AM; Traoré, HA, 2014) |
| "Cryptococcal meningitis has emerged as a leading cause of infectious morbidity and mortality in patients with AIDS." | 1.38 | A retrospective study of AIDS-associated cryptomeningitis. ( Chakrabarti, A; Randev, S; Sachdeva, RK; Sharma, A; Singh, S; Varma, S; Wanchu, A, 2012) |
| "Laryngeal histoplasmosis is very rare among patients with HIV and very few cases have so far been documented." | 1.37 | Hoarseness of voice in an AIDS patient: a rare presenting feature of disseminated histoplasmosis. ( Palfrey, J; Randall, CJ; Rowen, D; Sanmani, L, 2011) |
| "Fluconazole is a rare cause of severe cutaneous adverse drug reactions." | 1.35 | Severe cutaneous adverse drug reaction due to fluconazole. ( Brantley, JS; Kelly, BC; Kelso, RL; Lester, LJ; Petitt, MS; Wilkerson, MG, 2008) |
| "Of 101 AIDS patients with cryptococcal meningitis who received highly active antiretroviral therapy (HAART), 13 experienced cryptococcal IRIS." | 1.35 | Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. ( Anekthananon, T; Chetchotisakd, P; Filler, SG; Johnson, PC; Kendrick, AS; Kopetskie, H; Larsen, RA; Manosuthi, W; Morris, MI; Nolen, TL; Pappas, PG; Sobel, JD; Sungkanuparph, S; Supparatpinyo, K, 2009) |
| "Two patients with HIV/AIDS (CD4 counts of 8 and 81 cells/mm(3)) presented with altered mental status, visual changes, florid cryptococcal meningitis, and elevated ICP (>500 mm CSF) without evidence of hydrocephalus on computed tomography scan." | 1.33 | The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis. ( McGirt, MJ; Rigamonti, D; Williams, MA; Woodworth, GF, 2005) |
| "Fluconazole was the only systemic antifungal therapy available in our centre." | 1.33 | Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole. ( Maartens, G; Meintjes, GA; Morroni, C; Post, FA; Schaars, CF, 2006) |
| " Ventricular drainage and amphotericin B intraventricularly via an implanted tube into dilated ventricle could improve the clinical condition of serious cryptococcal meningitis and decrease the dosage of systemic use of amphotericin B, therefore, reduce the side-effects of the drugs." | 1.31 | [A clinical study of 26 cases of cryptococcal meningitis]. ( Li, T; Liu, Z; Qin, S; Sheng, R; Wang, A, 2002) |
| "The isolates were from AIDS patients who had either died or had failed to show a clinical response during amphotericin B (AMB) treatment." | 1.31 | In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy. ( Cahn, P; Canteros, C; Córdoba, S; Davel, G; Guelfand, L; Hochenfellner, F; Kaufman, S; Rodero, L, 2000) |
| "A patient with AIDS, treated with highly active antiretroviral therapy and trimethoprim-sulfamethoxazole, presented with confusion, a hemifield defect, and a mass lesion in the right occipital lobe." | 1.31 | Granulomatous amebic encephalitis in a patient with AIDS: isolation of acanthamoeba sp. Group II from brain tissue and successful treatment with sulfadiazine and fluconazole. ( Conde, C; Diz, J; Gonzalez-Mediero, G; Rodriguez De Lope, A; Santiago, P; Seijo Martinez, M; Visvesvara, GS, 2000) |
| "In separate trials in patients with AIDS, clinical response was similar with itraconazole (85%) and fluconazole (74%)." | 1.31 | Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS. ( Brizendine, E; Connolly, P; Haddad, N; Hafner, R; Le Monte, A; Wheat, LJ, 2002) |
| "isolates from HIV seropositive or AIDS patients with syntomatic oropharyngeal Candida infection." | 1.31 | "In vitro" antifungal activity of protease inhibitors. ( Deibis, L; Hartung de Capriles, C; Magaldi, S; Mata-Essayag, S; Perez, C; Verde, G, 2001) |
| " In order to determine the microsomal enzyme activity, the 6-beta-hydroxycortisol/17-hydroxycorticosteroid ratio and antipyrine pharmacokinetic parameters were determined." | 1.30 | Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients. ( Barthel, B; Brockmeyer, NH; Goos, M; Mertins, L; Tillmann, I, 1997) |
| "albicans by neutrophils in 10 AIDS patients and 50 control subjects." | 1.30 | Neutrophil phagocytosis in AIDS patients with azole resistant candidiasis. ( Castro, M; Diz Dios, P; Iglesias, I; Ocampo, A; Valcarcel, JP; Vazquez, E, 1997) |
| "albicans isolates in the mouth of AIDS patients with fluconazole resistance, and the difficulties in interpretation of present typing methods." | 1.30 | Variation in morphotype, karyotype and DNA type of fluconazole resistant Candida albicans from an AIDS patient. ( Anderson, MJ; Baily, GG; Birch, M; Denning, DW; Law, D; Takasuka, T, 1998) |
| "neoformans var." | 1.30 | Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients. ( Ghannoum, MA; Jessup, CJ; Mbidde, EK; Messer, SA; Pfaller, MA; Tumberland, M; Zhang, J, 1998) |
| "neofomans from 120 Ugandan AIDS patients with cryptococcal meningitis by analyzing their electrophoretic karyotypes and antifungal susceptibility profiles." | 1.30 | Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients. ( Ghannoum, M; Jessup, C; Mbidde, E; Messer, S; Pfaller, M; Tumberland, M; Zhang, J, 1998) |
| "isolated from the oral cavities of AIDS patients." | 1.30 | Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure. ( Burattini, MN; Colombo, AL; Costa, PR; Fischmann, O; Kallás, EG; Milan, EP, 1998) |
| "GM-CSF treatment of monocytes from AIDS patients increased fungistatic activity, and the combination of hrGM-CSF and fluconazole resulted in fungicidal activity." | 1.30 | Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients. ( Baldelli, F; Bistoni, F; Francisci, D; Preziosi, R; Tascini, C; Vecchiarelli, A, 1999) |
| "Two patients with AIDS developed microscopically verified focal cryptococcal lymphadenitis while treated with highly active anti-retroviral therapy for 8 and 15 months." | 1.30 | HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy. ( Blanche, P; Ginsburg, C; Gombert, B; Passeron, A; Rigolet, A; Salmon, D; Sicard, D; Stubei, I, 1998) |
| "In contrast, for patients with AIDS and oropharyngeal candidiasis infected with a single DNA subtype of C." | 1.29 | Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. ( Farinacci, G; Fothergill, AW; Pfaller, MA; Redding, SW; Rhine-Chalberg, J; Rinaldi, MG; Smith, J, 1994) |
| "Almost all patients with acquired immunodeficiency syndrome and successfully treated esophageal candidiasis develop a recurrence, usually within 2-3 months." | 1.29 | The natural history of esophageal candidiasis after successful treatment in patients with AIDS. ( Laine, L, 1994) |
| "Patients with cryptococcal meningitis tend to have recurrences of infection." | 1.29 | Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. ( Casadevall, A; Freundlich, LF; Spitzer, ED; Spitzer, SG, 1993) |
| "Product-limit survival and incidence of AIDS-defining events were calculated as a function of baseline CD4 count." | 1.29 | Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection. ( Cal, SX; Haslund, I; Jockusch, JD; Loss, SD; Nightingale, SD; Peterson, DM, 1993) |
| "Persons with hemophilia who receive multiple blood product transfusions from blood banks with little or no screening for infectious agents are at particularly high risk for infections with both HIV and T." | 1.29 | Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS. ( Acuña, G; Brengues, C; Cuny, G; Labarca, J; Muñoz, S; Oddó, D; Saavedra, H; Sepúlveda, C; Solari, A; Veas, F, 1993) |
| "The fluconazole dosages were as follows: 0." | 1.29 | Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model. ( Barchiesi, F; Graybill, JR; Luther, MF; Najvar, LK; Rinaldi, MG; Scalise, G, 1996) |
| "The posterior uveitis was characterized by white-yellow inflammatory opacities located in the inferior and posterior vitreous." | 1.29 | Inflammatory opacities of the vitreous in rifabutin-associated uveitis. ( Brooks, SE; Chaknis, MJ; Marcus, DM; Mitchell, KT, 1996) |
| "Eighteen consecutive AIDS patients with a first episode of cryptococcal meningitis were enrolled in the study to evaluate the efficacy and tolerability of amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS." | 1.29 | Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS. ( Jaruratanasirikul, S, 1996) |
| "We present here three AIDS patients with disseminated cryptococcal infection and lung involvement." | 1.28 | [Pulmonary cryptococcosis in AIDS]. ( Ariza, J; Carratalà, J; Martos, A; Mascaró, J; Podzamczer, D; Santín, M, 1992) |
| "A 53-yr-old man, known to have had AIDS for 6 months, developed the clinical signs and symptoms of porphyria cutanea tarda (PCT) preceding deterioration of his illness." | 1.28 | Porphyria cutanea tarda in a patient with AIDS. ( Lustermans, FA; Russel, MG; van Pelt, J; Wuite, J, 1992) |
| "Thirty adults (15 with ARC and 15 with AIDS) with a first episode of thrush candidiasis were given oral fluconazole (Triflucan 50 mg; one capsule daily) for at least three months." | 1.28 | [Treatment and secondary prophylaxis with fluconazole for oropharyngeal candidiasis in HIV-positive patients. A mycological analysis of failures]. ( André, D; Bastide, JM; Janbon, F; Mallié, M; Reynes, J, 1992) |
| "Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) is particularly common in tropical Africa." | 1.28 | Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatment with fluconazole. ( Aubry, P; Bogaerts, J; Dupont, B; Durbec, JP; Kadio, A; Laroche, R; Latif, A; M'Pele, P; Taelman, H; Touze, JE, 1992) |
| "Eight patients with AIDS were treated orally with 800 mg of fluconazole daily for cryptococcal meningitis for a mean duration of 4." | 1.28 | Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. ( Berry, AJ; Graybill, JR; Rinaldi, MG, 1992) |
| "Fluconazole has shown effectiveness in maintenance therapy, being not be possible to evaluate it as an acute phase therapy because the low number of cases in which it was studied." | 1.28 | [Cryptococcosis in AIDS patients: a study of 19 cases]. ( Adrados de Llano, M; García Aguado, C; Gazapo Carretero, E; González Lahoz, JM; Martínez Blanco, ML; Verdejo Ortes, J, 1992) |
| "Fluconazole was well tolerated in all the patients." | 1.28 | [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes]. ( García Puig, J; Gil, A; Khamashta, M; Lavilla, P; López Dupla, M; Ortiz-Vázquez, J; Pintado, V; Valencia, E, 1992) |
| " Because amphotericin B nephrotoxicity was suspected, further intravenous administration was stopped after a cumulative dosage of 2 g." | 1.28 | [Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole]. ( Glück, T; Weber, P; Wiedmann, KH, 1991) |
| "Viral esophagitis was identified in 13 cases (eight herpes simplex virus and five cytomegalovirus), and an esophagitis of unknown origin was documented in two patients." | 1.28 | Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment. ( Bianchi Porro, G; Cernuschi, M; Lazzarin, A; Parente, F; Rizzardini, G; Valsecchi, L, 1991) |
| "An AIDS patient with a subdural empyema as a complication of candida sinusitis is presented." | 1.28 | Successfully treated candida sinusitis in an AIDS patient. ( Castro, A; Colmenero, C; Moñux, A; Valencia, E, 1990) |
| "To meet criteria for adequate treatment of meningitis all patients had two sequential cerebrospinal fluid samples which were culture negative." | 1.28 | Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group. ( Bozzette, S; Chiu, J; Larsen, RA; Leal, MA; McCutchan, JA; Richman, DD, 1989) |
| "Treatment with amphotericin B followed by fluconazole was effective." | 1.28 | Disseminated histoplasmosis in a Danish patient with AIDS. ( Franzmann, M; Mathiesen, LR; Smith, E, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (8.29) | 18.7374 |
| 1990's | 132 (60.83) | 18.2507 |
| 2000's | 37 (17.05) | 29.6817 |
| 2010's | 22 (10.14) | 24.3611 |
| 2020's | 8 (3.69) | 2.80 |
| Authors | Studies |
|---|---|
| Dhanani, JA | 1 |
| Lipman, J | 1 |
| Pincus, J | 1 |
| Townsend, S | 1 |
| Livermore, A | 1 |
| Wallis, SC | 1 |
| Abdul-Aziz, MH | 1 |
| Roberts, JA | 1 |
| Ohnishi, YO | 1 |
| Pantoja, ASL | 1 |
| Abraão, LSO | 1 |
| Alves, NG | 1 |
| Ohnishi, MDO | 1 |
| Libonati, RMF | 1 |
| Ventura, AMRDS | 1 |
| Palácios, VRDCM | 1 |
| Samukawa, S | 3 |
| Yoshimi, R | 3 |
| Kojitani, N | 3 |
| Uzawa, Y | 3 |
| Takase-Minegishi, K | 3 |
| Kirino, Y | 3 |
| Soejima, Y | 3 |
| Kato, H | 3 |
| Nakajima, H | 3 |
| Lalloo, UG | 1 |
| Komarow, L | 1 |
| Aberg, JA | 2 |
| Clifford, DB | 1 |
| Hogg, E | 1 |
| McKhann, A | 1 |
| Bukuru, A | 1 |
| Lagat, D | 1 |
| Pillay, S | 1 |
| Mave, V | 1 |
| Supparatpinyo, K | 2 |
| Samaneka, W | 1 |
| Langat, D | 1 |
| Ticona, E | 2 |
| Badal-Faesen, S | 1 |
| Larsen, RA | 7 |
| Zhang, Y | 1 |
| Cooper, B | 1 |
| Gui, X | 1 |
| Sherer, R | 1 |
| Cao, Q | 1 |
| Williams, SC | 1 |
| Sweeney, J | 1 |
| Parameswaran, L | 1 |
| Kalinoski, T | 1 |
| Malenfant, J | 1 |
| Yim, C | 1 |
| Jeng, A | 1 |
| O'Connor, L | 1 |
| Van Anh, D | 1 |
| Chau, TTH | 1 |
| Chau, NVV | 1 |
| Huong, LNP | 1 |
| Wolbers, M | 1 |
| Day, JN | 1 |
| Shi, T | 1 |
| Wu, L | 1 |
| Cai, J | 1 |
| Chen, H | 1 |
| de Carvalho Santana, R | 1 |
| Schiave, LA | 1 |
| Dos Santos Quaglio, AS | 1 |
| de Gaitani, CM | 1 |
| Martinez, R | 1 |
| Borges, MASB | 1 |
| de Araújo Filho, JA | 1 |
| Oliveira, BJS | 1 |
| Moreira, IS | 1 |
| de Paula, VV | 1 |
| de Bastos, AL | 1 |
| Soares, RBA | 1 |
| Turchi, MD | 1 |
| Minta, DK | 1 |
| Traoré, AM | 1 |
| Coulibaly, I | 1 |
| Diallo, K | 1 |
| Soukho-Kaya, A | 1 |
| Dolo, A | 1 |
| Kamaté, B | 1 |
| Ouologuem, DS | 1 |
| Dembélé, M | 1 |
| Traoré, HA | 1 |
| Chabasse, D | 1 |
| Pichard, E | 1 |
| Sakamoto, N | 1 |
| Maeda, T | 1 |
| Mikita, K | 1 |
| Kato, Y | 1 |
| Yanagisawa, N | 1 |
| Suganuma, A | 1 |
| Imamura, A | 1 |
| Nakamura-Uchiyama, F | 1 |
| Miyahira, Y | 1 |
| Kawana, A | 1 |
| Ohnishi, K | 1 |
| Ajisawa, A | 1 |
| Meulendyke, KA | 1 |
| Queen, SE | 1 |
| Engle, EL | 1 |
| Shirk, EN | 1 |
| Liu, J | 1 |
| Steiner, JP | 1 |
| Nath, A | 1 |
| Tarwater, PM | 1 |
| Graham, DR | 1 |
| Mankowski, JL | 1 |
| Zink, MC | 1 |
| Nelwan, EJ | 1 |
| Indrasanti, E | 1 |
| Sinto, R | 1 |
| Nurchaida, F | 1 |
| Sosrosumihardjo, R | 1 |
| Gago, S | 1 |
| Serrano, C | 1 |
| Alastruey-Izquierdo, A | 1 |
| Cuesta, I | 1 |
| Martín-Mazuelos, E | 1 |
| Aller, AI | 1 |
| Gómez-López, A | 1 |
| Mellado, E | 2 |
| Lofgren, S | 1 |
| Abassi, M | 1 |
| Rhein, J | 1 |
| Boulware, DR | 2 |
| Cartwright, E | 1 |
| Rouphael, N | 1 |
| Jain, S | 1 |
| Ilksoy, N | 1 |
| Dammert, P | 1 |
| Bustamante, B | 1 |
| Llanos-Cuentas, A | 1 |
| Huaroto, L | 1 |
| Chávez, VM | 1 |
| Campos, PE | 1 |
| Lester, LJ | 1 |
| Brantley, JS | 1 |
| Kelso, RL | 1 |
| Kelly, BC | 1 |
| Petitt, MS | 1 |
| Wilkerson, MG | 1 |
| Sungkanuparph, S | 1 |
| Filler, SG | 1 |
| Chetchotisakd, P | 2 |
| Pappas, PG | 1 |
| Nolen, TL | 1 |
| Manosuthi, W | 1 |
| Anekthananon, T | 1 |
| Morris, MI | 1 |
| Kopetskie, H | 1 |
| Kendrick, AS | 1 |
| Johnson, PC | 1 |
| Sobel, JD | 1 |
| Drake, KW | 1 |
| Adam, RD | 1 |
| Persad, P | 1 |
| Patel, R | 2 |
| Stephens, J | 1 |
| Francis-Rogers, S | 1 |
| Talat, P | 1 |
| Mijiti, J | 1 |
| Pu, XM | 1 |
| Erfan, A | 1 |
| Yaguchi, T | 1 |
| Chibana, H | 1 |
| Tanaka, R | 1 |
| Mathisen, G | 1 |
| Shelub, A | 1 |
| Truong, J | 1 |
| Wigen, C | 1 |
| Kothavade, RJ | 1 |
| Oberai, CM | 1 |
| Valand, AG | 1 |
| Panthaki, MH | 1 |
| Sanmani, L | 1 |
| Randall, CJ | 1 |
| Palfrey, J | 1 |
| Rowen, D | 1 |
| Jariwala, S | 1 |
| Vernon, N | 1 |
| de Vos, G | 1 |
| Basu, S | 1 |
| Kumar, A | 1 |
| Ondounda, M | 1 |
| Mounguengui, D | 1 |
| Mandji, LJ | 1 |
| Magne, C | 1 |
| Nziengui, MM | 1 |
| Kombila, U | 1 |
| Nzenze, JR | 1 |
| Sachdeva, RK | 1 |
| Randev, S | 1 |
| Sharma, A | 1 |
| Wanchu, A | 1 |
| Chakrabarti, A | 1 |
| Singh, S | 1 |
| Varma, S | 1 |
| Jackson, AT | 1 |
| Nussbaum, JC | 1 |
| Phulusa, J | 1 |
| Namarika, D | 1 |
| Chikasema, M | 1 |
| Kanyemba, C | 1 |
| Jarvis, JN | 1 |
| Jaffar, S | 1 |
| Hosseinipour, MC | 1 |
| van der Horst, C | 2 |
| Harrison, TS | 1 |
| Jackson, A | 1 |
| Castro, LÁ | 1 |
| Álvarez, MI | 1 |
| Martínez, E | 1 |
| King, MD | 1 |
| Perlino, CA | 1 |
| Cinnamon, J | 1 |
| Jernigan, JA | 1 |
| Liu, Z | 1 |
| Wang, A | 1 |
| Li, T | 1 |
| Qin, S | 1 |
| Sheng, R | 1 |
| Khan, ZU | 1 |
| Al-Anezi, AA | 1 |
| Chandy, R | 1 |
| Xu, J | 1 |
| Fonseca, EM | 1 |
| Nuño, FJ | 1 |
| García-Alcalde, ML | 1 |
| Menéndez, MJ | 1 |
| Mootsikapun, P | 1 |
| Anunnatsiri, S | 1 |
| Choksawadphinyo, K | 1 |
| Momoff, N | 1 |
| Parrish, A | 1 |
| Rodero, L | 2 |
| Rodriguez, AC | 1 |
| Salve, A | 1 |
| Guelfand, L | 2 |
| Cahn, P | 2 |
| Cuenca-Estrella, M | 1 |
| Davel, G | 2 |
| Rodriguez-Tudela, JL | 3 |
| Panomvana Na Ayudhya, D | 1 |
| Thanompuangseree, N | 1 |
| Tansuphaswadikul, S | 2 |
| Huang, YW | 1 |
| Chang, CC | 1 |
| Sun, HY | 1 |
| Chen, MY | 1 |
| Hung, CC | 1 |
| Chang, SC | 1 |
| Jenny-Avital, E | 2 |
| Hrovatin, E | 1 |
| Zardo, F | 1 |
| Brieda, M | 1 |
| Dametto, E | 1 |
| Piazza, R | 1 |
| Antonini-Canterin, F | 1 |
| Cassin, M | 1 |
| Meneguzzo, N | 1 |
| Viel, E | 1 |
| Lestuzzi, C | 1 |
| Di Gennaro, G | 1 |
| Nicolosi, GL | 1 |
| Wheat, LJ | 4 |
| Musial, CE | 1 |
| Woodworth, GF | 1 |
| McGirt, MJ | 1 |
| Williams, MA | 1 |
| Rigamonti, D | 1 |
| Skiest, DJ | 1 |
| Hester, LJ | 1 |
| Hardy, RD | 1 |
| Connolly, P | 3 |
| Smedema, M | 2 |
| Durkin, M | 1 |
| Brizendine, E | 3 |
| Mann, P | 1 |
| McNicholas, PM | 1 |
| Goldman, M | 1 |
| Schaars, CF | 1 |
| Meintjes, GA | 1 |
| Morroni, C | 1 |
| Post, FA | 1 |
| Maartens, G | 1 |
| Maek-a-Nantawat, W | 1 |
| Phonrat, B | 1 |
| Boonpokbn, L | 1 |
| Mctm, AG | 1 |
| Pitisuttithum, P | 1 |
| Lortholary, O | 1 |
| Barbaro, G | 2 |
| Barbarini, G | 1 |
| Di Lorenzo, G | 2 |
| Genet, P | 1 |
| Pulik, M | 1 |
| Lionnet, F | 1 |
| Petitdidier, C | 1 |
| Touahri, T | 1 |
| De Jonghe, B | 1 |
| Hay, RJ | 2 |
| Israel, L | 1 |
| Sadigh, M | 1 |
| Lewin, SR | 1 |
| Street, AC | 1 |
| Garcia-Hermoso, D | 1 |
| Dromer, F | 1 |
| Improvisi, L | 1 |
| Provost, F | 1 |
| Dupont, B | 4 |
| Laguna, F | 2 |
| Martínez-Suárez, JV | 2 |
| Adrados, M | 1 |
| Enríquez, A | 1 |
| Dewsnup, DH | 1 |
| Stevens, DA | 3 |
| Paugam, A | 3 |
| Dupouy-Camet, J | 3 |
| Blanche, P | 2 |
| Gangneux, JP | 1 |
| Tourte-Schaefer, C | 3 |
| Sicard, D | 2 |
| Pfaller, MA | 2 |
| Rhine-Chalberg, J | 1 |
| Redding, SW | 1 |
| Smith, J | 1 |
| Farinacci, G | 1 |
| Fothergill, AW | 1 |
| Rinaldi, MG | 4 |
| Wilcox, CM | 1 |
| Becherer, PR | 1 |
| Sokol-Anderson, M | 1 |
| Joist, JH | 1 |
| Milligan, T | 1 |
| Yeates, RA | 1 |
| Ruhnke, M | 3 |
| Pfaff, G | 1 |
| Hartmann, A | 1 |
| Trautmann, M | 1 |
| Sarnow, E | 1 |
| Ramirez, JA | 1 |
| Srinath, L | 1 |
| Ahkee, S | 1 |
| Huang, AK | 1 |
| Raff, MJ | 1 |
| Laine, L | 2 |
| Degreef, HJ | 1 |
| DeDoncker, PR | 1 |
| Spitzer, ED | 1 |
| Spitzer, SG | 1 |
| Freundlich, LF | 1 |
| Casadevall, A | 2 |
| Nightingale, SD | 1 |
| Jockusch, JD | 1 |
| Haslund, I | 1 |
| Cal, SX | 1 |
| Peterson, DM | 1 |
| Loss, SD | 1 |
| Thevenot, T | 1 |
| Colardelle, P | 1 |
| Chochon, M | 1 |
| Andrieu, J | 1 |
| DeMuria, D | 1 |
| Forrest, A | 1 |
| Rich, J | 1 |
| Scavone, JM | 1 |
| Cohen, LG | 1 |
| Kazanjian, PH | 1 |
| Polanco, AM | 1 |
| Sandven, P | 1 |
| Bjørneklett, A | 1 |
| Maeland, A | 1 |
| Sitbon, O | 1 |
| Fourme, T | 1 |
| Boureé, P | 1 |
| Du Pasquier, L | 1 |
| Salmeron, S | 1 |
| Loschiavo, F | 1 |
| Ventura-Spagnolo, T | 1 |
| Sessa, E | 1 |
| Bramanti, P | 1 |
| Velez, JD | 1 |
| Allendoerfer, R | 1 |
| Luther, M | 1 |
| Graybill, JR | 6 |
| Solari, A | 1 |
| Saavedra, H | 1 |
| Sepúlveda, C | 1 |
| Oddó, D | 1 |
| Acuña, G | 1 |
| Labarca, J | 1 |
| Muñoz, S | 1 |
| Cuny, G | 1 |
| Brengues, C | 1 |
| Veas, F | 1 |
| Sharkey-Mathis, PK | 1 |
| Velez, J | 1 |
| Fetchick, R | 1 |
| Barchiesi, F | 2 |
| Morbiducci, V | 1 |
| Ancarani, F | 1 |
| Arzeni, D | 1 |
| Scalise, G | 2 |
| Goa, KL | 1 |
| Barradell, LB | 1 |
| Guillaume, MP | 1 |
| De Prez, C | 1 |
| Cogan, E | 1 |
| Le Guennec, R | 1 |
| Reynes, J | 2 |
| Mallié, M | 2 |
| Pujol, C | 1 |
| Janbon, F | 2 |
| Bastide, JM | 2 |
| Zingman, BS | 1 |
| Najvar, LK | 1 |
| Luther, MF | 1 |
| Torrús, D | 1 |
| Boix, V | 1 |
| Massa, B | 1 |
| Portilla, J | 1 |
| Pérez-Mateo, M | 1 |
| Chaknis, MJ | 1 |
| Brooks, SE | 1 |
| Mitchell, KT | 1 |
| Marcus, DM | 1 |
| Feldmesser, M | 1 |
| Harris, C | 1 |
| Reichberg, S | 1 |
| Khan, S | 1 |
| Manfredi, R | 1 |
| Moroni, A | 1 |
| Mazzoni, A | 1 |
| Nanetti, A | 1 |
| Donati, M | 1 |
| Mastroianni, A | 1 |
| Coronado, OV | 1 |
| Chiodo, F | 1 |
| Maenza, JR | 1 |
| Merz, WG | 1 |
| Romagnoli, MJ | 1 |
| Keruly, JC | 1 |
| Moore, RD | 1 |
| Gallant, JE | 1 |
| Kelly, SL | 1 |
| Lamb, DC | 1 |
| Kelly, DE | 1 |
| Manning, NJ | 1 |
| Loeffler, J | 2 |
| Hebart, H | 2 |
| Schumacher, U | 2 |
| Einsele, H | 2 |
| Shapiro, BD | 1 |
| Ehrenpreis, ED | 1 |
| Tomaka, FL | 1 |
| Bonner, GF | 1 |
| Secrest, KM | 1 |
| Cheney, LM | 1 |
| Troke, PF | 2 |
| Jaruratanasirikul, S | 1 |
| Brockmeyer, NH | 1 |
| Tillmann, I | 1 |
| Mertins, L | 1 |
| Barthel, B | 1 |
| Goos, M | 1 |
| Shinohara, YT | 1 |
| Tasker, SA | 1 |
| Diz Dios, P | 1 |
| Iglesias, I | 1 |
| Valcarcel, JP | 1 |
| Ocampo, A | 1 |
| Vazquez, E | 1 |
| Castro, M | 1 |
| Takasuka, T | 1 |
| Baily, GG | 1 |
| Birch, M | 1 |
| Anderson, MJ | 1 |
| Law, D | 1 |
| Denning, DW | 2 |
| Jessup, CJ | 1 |
| Messer, SA | 1 |
| Zhang, J | 2 |
| Tumberland, M | 2 |
| Mbidde, EK | 1 |
| Ghannoum, MA | 1 |
| Davey, KG | 1 |
| Johnson, EM | 1 |
| Holmes, AD | 1 |
| Szekely, A | 1 |
| Warnock, DW | 1 |
| Luchi, M | 1 |
| Saberhagen, C | 1 |
| Hinthorn, D | 1 |
| Hegener, P | 1 |
| Fätkenheuer, G | 1 |
| Diehl, V | 1 |
| Pfaller, M | 1 |
| Messer, S | 1 |
| Mbidde, E | 1 |
| Jessup, C | 1 |
| Ghannoum, M | 1 |
| Milan, EP | 1 |
| Burattini, MN | 1 |
| Kallás, EG | 1 |
| Fischmann, O | 1 |
| Costa, PR | 1 |
| Colombo, AL | 1 |
| Tascini, C | 1 |
| Vecchiarelli, A | 1 |
| Preziosi, R | 1 |
| Francisci, D | 1 |
| Bistoni, F | 1 |
| Baldelli, F | 1 |
| Gombert, B | 1 |
| Ginsburg, C | 1 |
| Passeron, A | 1 |
| Stubei, I | 1 |
| Rigolet, A | 1 |
| Salmon, D | 1 |
| Finkelstein, DM | 1 |
| Schoenfeld, DA | 1 |
| Mondon, P | 1 |
| Petter, R | 1 |
| Amalfitano, G | 1 |
| Luzzati, R | 1 |
| Concia, E | 1 |
| Polacheck, I | 1 |
| Kwon-Chung, KJ | 1 |
| Goldani, LZ | 1 |
| Aquino, VR | 1 |
| Dargél, AA | 1 |
| Córdoba, S | 1 |
| Hochenfellner, F | 1 |
| Canteros, C | 1 |
| Kaufman, S | 1 |
| Hagmeyer, L | 1 |
| Henke, N | 1 |
| Schmidt-Westhausen, A | 1 |
| Morschhäuser, J | 1 |
| Seijo Martinez, M | 1 |
| Gonzalez-Mediero, G | 1 |
| Santiago, P | 1 |
| Rodriguez De Lope, A | 1 |
| Diz, J | 1 |
| Conde, C | 1 |
| Visvesvara, GS | 1 |
| Baleta, A | 1 |
| Ford, BJ | 1 |
| Maebashi, K | 1 |
| Niimi, M | 1 |
| Kudoh, M | 1 |
| Fischer, FJ | 1 |
| Makimura, K | 1 |
| Niimi, K | 1 |
| Piper, RJ | 1 |
| Uchida, K | 1 |
| Arisawa, M | 1 |
| Cannon, RD | 1 |
| Yamaguchi, H | 1 |
| Brundtlandt, GH | 1 |
| Nabarro, D | 1 |
| Annan, K | 1 |
| Wang, W | 1 |
| Li, R | 1 |
| Wang, D | 1 |
| Li, S | 1 |
| Zhu, L | 1 |
| Wang, X | 1 |
| Wan, Z | 1 |
| Zhai, W | 1 |
| Hafner, R | 2 |
| Haddad, N | 1 |
| Le Monte, A | 1 |
| Mata-Essayag, S | 1 |
| Magaldi, S | 1 |
| Hartung de Capriles, C | 1 |
| Deibis, L | 1 |
| Verde, G | 1 |
| Perez, C | 1 |
| Price, RW | 1 |
| Heeren, DM | 1 |
| Bredt, B | 1 |
| Rambeloarisoa, J | 1 |
| Batisse, D | 1 |
| Thiebaut, JB | 1 |
| Mikol, J | 1 |
| Mrejen, S | 1 |
| Karmochkine, M | 1 |
| Kazatchkine, MD | 1 |
| Weiss, L | 1 |
| Piketty, C | 1 |
| Martos, A | 1 |
| Mascaró, J | 1 |
| Santín, M | 1 |
| Ariza, J | 1 |
| Carratalà, J | 1 |
| Podzamczer, D | 1 |
| Habert, M | 1 |
| Dretler, RH | 1 |
| Conteas, CN | 1 |
| Tuazon, C | 1 |
| Koster, FM | 1 |
| Sattler, F | 1 |
| Squires, K | 1 |
| Islam, MZ | 1 |
| Viviani, MA | 1 |
| Eloy, O | 1 |
| Joly, V | 1 |
| Ghnassia, JC | 1 |
| Carbon, C | 1 |
| Yeni, P | 1 |
| Russel, MG | 1 |
| Lustermans, FA | 1 |
| Wuite, J | 1 |
| van Pelt, J | 1 |
| André, D | 1 |
| Powderly, WG | 3 |
| Saag, MS | 2 |
| Cloud, GA | 2 |
| Robinson, P | 3 |
| Meyer, RD | 1 |
| Jacobson, JM | 1 |
| Sugar, AM | 4 |
| McAuliffe, VJ | 1 |
| Follansbee, SE | 1 |
| Coker, RJ | 2 |
| Moulopoulos, D | 1 |
| Main, J | 1 |
| Murphy, SM | 1 |
| Pinching, AJ | 2 |
| Harris, JR | 3 |
| Haglund, LA | 1 |
| Greenfield, RA | 1 |
| Lavilla Uriol, P | 1 |
| Gil, A | 3 |
| Valencia, E | 4 |
| Pintado, V | 3 |
| López Dupla, M | 2 |
| Khamashta, M | 2 |
| García Puig, J | 2 |
| Ortiz Vázquez, J | 1 |
| Santamaría, JM | 2 |
| Zubero, Z | 2 |
| Laroche, R | 1 |
| Touze, JE | 1 |
| Taelman, H | 1 |
| Bogaerts, J | 1 |
| Kadio, A | 1 |
| M'Pele, P | 1 |
| Latif, A | 1 |
| Aubry, P | 1 |
| Durbec, JP | 1 |
| González Quijada, S | 1 |
| Pedrajas Navas, JM | 1 |
| Borregón Carretero, SJ | 1 |
| Téllez Molina, J | 1 |
| Berry, AJ | 1 |
| Gazapo Carretero, E | 1 |
| García Aguado, C | 1 |
| Adrados de Llano, M | 1 |
| Martínez Blanco, ML | 1 |
| Verdejo Ortes, J | 1 |
| González Lahoz, JM | 1 |
| Lavilla, P | 2 |
| Ortiz-Vázquez, J | 2 |
| Lange, JM | 1 |
| Reiss, P | 1 |
| Zalcman, G | 1 |
| Lechapt, E | 1 |
| Milleron, B | 1 |
| Denis, M | 1 |
| Mayaud, C | 1 |
| Akoun, G | 1 |
| Grieco, MH | 1 |
| Sharkey, PK | 1 |
| Thompson, SE | 1 |
| Tuazon, CU | 1 |
| Fisher, JF | 1 |
| Greene, SI | 1 |
| Lang, OS | 1 |
| Smith, D | 1 |
| Boag, F | 1 |
| Midgley, J | 1 |
| Gazzard, B | 1 |
| Glück, T | 1 |
| Weber, P | 1 |
| Wiedmann, KH | 1 |
| Just-Nübling, G | 1 |
| Gentschew, G | 1 |
| Meissner, K | 1 |
| Odewald, J | 1 |
| Staszewski, S | 1 |
| Helm, EB | 1 |
| Stille, W | 1 |
| Gradon, JD | 1 |
| Sepkowitz, DV | 1 |
| Willocks, L | 1 |
| Leen, CL | 3 |
| Brettle, RP | 1 |
| Urquhart, D | 1 |
| Russell, TB | 1 |
| Milne, LJ | 1 |
| Di Donato, C | 1 |
| Viguié, C | 1 |
| Vicens, I | 1 |
| Volle, PJ | 1 |
| Bozzette, SA | 2 |
| Chiu, J | 3 |
| Leal, MA | 4 |
| Tilles, JG | 1 |
| Richman, DD | 2 |
| Leedom, JM | 1 |
| McCutchan, JA | 3 |
| Vincent-Ballereau, FN | 1 |
| Patey, ON | 1 |
| Lafaix, C | 1 |
| Blancard, A | 1 |
| Moulin-Traffort, J | 1 |
| Regli, P | 1 |
| Sarzier, JM | 1 |
| Quilici, M | 1 |
| Buxton, MJ | 1 |
| Dubois, DJ | 1 |
| Turner, RR | 1 |
| Sculpher, MJ | 1 |
| Robinson, PA | 1 |
| Searcy, C | 1 |
| Zar, FA | 1 |
| Fernandez, M | 1 |
| De Wit, S | 2 |
| Urbain, D | 1 |
| Rahir, F | 1 |
| Weerts, D | 2 |
| Clumeck, N | 2 |
| Dupla, ML | 1 |
| Khamashta, MA | 1 |
| García-Puig, J | 1 |
| Parente, F | 1 |
| Cernuschi, M | 1 |
| Rizzardini, G | 1 |
| Lazzarin, A | 1 |
| Valsecchi, L | 1 |
| Bianchi Porro, G | 1 |
| Colmenero, C | 1 |
| Moñux, A | 1 |
| Castro, A | 1 |
| Gill, SK | 1 |
| Jacobsen, J | 1 |
| Rothman, P | 1 |
| Gilbert, G | 1 |
| Tilles, J | 1 |
| Lucatorto, FM | 1 |
| Franker, C | 1 |
| Hardy, WD | 1 |
| Chafey, S | 1 |
| Good, CB | 1 |
| Leeper, HF | 1 |
| Poizot-Martin, I | 1 |
| Grob, JJ | 1 |
| Fournerie, JR | 1 |
| Dhiver, C | 1 |
| Andrac, L | 1 |
| Gastaut, JA | 1 |
| Bonerandi, JJ | 1 |
| Muńoz, P | 1 |
| Moreno, S | 1 |
| Berenguer, J | 1 |
| Bernaldo de Quirós, JC | 1 |
| Bouza, E | 1 |
| Fox, R | 1 |
| Neal, KR | 1 |
| Ellis, ME | 2 |
| Mandal, BK | 2 |
| Kitchen, VS | 1 |
| Savage, M | 1 |
| Meissner, GF | 1 |
| Koletar, SL | 1 |
| Russell, JA | 1 |
| Fass, RJ | 1 |
| Plouffe, JF | 1 |
| Muñoz, J | 1 |
| Teira, R | 1 |
| Alvarez, M | 1 |
| Cisterna, R | 1 |
| Heise, W | 1 |
| Arasteh, K | 1 |
| L'age, M | 1 |
| Ruf, B | 1 |
| Mares, M | 1 |
| Sartori, MT | 1 |
| Carretta, M | 1 |
| Bertaggia, A | 1 |
| Girolami, A | 1 |
| Lucey, DR | 1 |
| Lucey, CR | 1 |
| Galgiani, JN | 1 |
| Chan, LS | 1 |
| Dunbar, EM | 1 |
| Meunier, F | 1 |
| Tomlinson, DR | 1 |
| Parkin, J | 1 |
| Lombardi, G | 1 |
| Gramegna, G | 1 |
| Cavanna, C | 1 |
| Michelone, G | 1 |
| Nightingale, SL | 1 |
| Freeman, EM | 1 |
| Ansari, AM | 1 |
| Gould, IM | 1 |
| Douglas, JG | 1 |
| Chin, T | 1 |
| Fong, IW | 1 |
| Vandenbroucke, A | 1 |
| Esposito, R | 1 |
| Foppa, CU | 1 |
| Antinori, S | 1 |
| Chave, JP | 1 |
| Cajot, A | 1 |
| Bille, J | 1 |
| Glauser, MP | 1 |
| Dietrich, D | 1 |
| Oka, S | 1 |
| Tokitsu, M | 1 |
| Mori, H | 1 |
| Nakata, H | 1 |
| Goto, M | 1 |
| Goto, H | 1 |
| Shimada, K | 1 |
| Keil, TU | 1 |
| Bozzette, S | 1 |
| Nathwani, D | 1 |
| Green, ST | 1 |
| McGuire, W | 1 |
| Goldberg, DJ | 1 |
| Kennedy, DH | 1 |
| Tozzi, V | 1 |
| Bordi, E | 1 |
| Galgani, S | 1 |
| Leoni, GC | 1 |
| Narciso, P | 1 |
| Sette, P | 1 |
| Visco, G | 1 |
| Bernard, E | 1 |
| Carles, M | 1 |
| Toussaint-Gari, M | 1 |
| Fournier, JP | 1 |
| Dellamonica, P | 1 |
| Smith, E | 1 |
| Franzmann, M | 1 |
| Mathiesen, LR | 1 |
| Goossens, H | 1 |
| Byrne, WR | 1 |
| Wajszczuk, CP | 1 |
| Walsh, TJ | 1 |
| Stern, JJ | 1 |
| Hartman, BJ | 1 |
| Sharkey, P | 1 |
| Rowland, V | 1 |
| Squires, KE | 1 |
| Murray, HW | 1 |
| Saunders, C | 1 |
| Drouhet, E | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 1 Safety Run-in Study and Phase 1b Randomized, Double Blinded, Placebo Controlled Trial[NCT05695521] | Phase 1 | 66 participants (Anticipated) | Interventional | 2023-04-03 | Recruiting | ||
| A Randomized Study of the MitraClip Device in Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation[NCT01772108] | 42 participants (Actual) | Interventional | 2013-04-30 | Terminated (stopped due to As recruitment rate was lower than anticipated) | |||
| Flow Cytometry Study of T Cell Responses to HIV Vaccines[NCT00068978] | 200 participants | Observational | 2003-04-30 | Completed | |||
| A Randomized Comparative Multicenter Trial of Fluconazole and Ketoconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients[NCT00002304] | 0 participants | Interventional | Completed | ||||
| Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome[NCT00002074] | 0 participants | Interventional | Completed | ||||
| Comparison of Fluconazole (UK-49,858) and Amphotericin B for Maintenance Treatment of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome[NCT00001017] | Phase 3 | 330 participants | Interventional | Completed | |||
| Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis[NCT00000708] | 120 participants | Interventional | Completed | ||||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
21 reviews available for fluconazole and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Clinical diversity of invasive cryptococcosis in AIDS patients from central China: report of two cases with review of literature.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amphotericin B; Antifungal Agents; Antigen | 2019 |
Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV | 2017 |
New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 2012 |
Diagnosis and management of central nervous system histoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Fluconaz | 2005 |
Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; An | 2005 |
Candida epiglottitis in an adult with acquired immunodeficiency syndrome treated with oral fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Epiglottitis; Female; Fluconazole; Humans | 1995 |
Current therapy of dermatophytosis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Administration, Topical; Allylamine; Antif | 1994 |
Management of systemic manifestations of fungal disease in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Coccidioidomycosis; Cryptococcosis; Drug Therapy | 1994 |
Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Animals; Antifungal Agent | 1995 |
Subacute mitochondrial liver disease in a patient with AIDS: possible relationship to prolonged fluconazole administration.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Opportunistic Infections; Ant | 1996 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Th | 1992 |
Therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Animals; Fluconazole; Flucytosine; Humans; Menin | 1992 |
[Pleuropulmonary cryptococcosis disclosing AIDS].
Topics: Acquired Immunodeficiency Syndrome; CD4-Positive T-Lymphocytes; Cryptococcosis; Fluconazole; Humans; | 1991 |
Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections.
Topics: Acquired Immunodeficiency Syndrome; Fluconazole; Humans; Mycoses; Opportunistic Infections | 1991 |
Overview: cryptococcosis in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Fluconazole; Flucytosine; Humans | 1991 |
[Mollusca contagiosa-like cutaneous cryptococcosis in AIDS: a case].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Dermatomycoses; Diagnosis | 1991 |
[Cryptococcosis in AIDS: therapeutic concepts].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Therapy, Combination; Fluco | 1990 |
Azoles and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ke | 1990 |
Fluconazole, a new antifungal agent.
Topics: Acquired Immunodeficiency Syndrome; Fluconazole; Humans; Mycoses | 1990 |
[Current progress in antifungal therapy: the value of fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningit | 1990 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; D | 1987 |
29 trials available for fluconazole and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combinat | 2023 |
Antifungal Susceptibility Does Not Correlate With Fungal Clearance or Survival in AIDS-Associated Cryptococcal Meningitis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Fluconazole; Flucytosine; Humans; Meningitis, | 2021 |
A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Opportunistic In | 2012 |
The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 2003 |
Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antibiotics, Antitubercular; Antifungal Agents; Area Unde | 2004 |
Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Do | 2006 |
Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1995 |
Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candida; Candidiasis, Oral; Drug Resistance, Microbial; F | 1995 |
The pharmacokinetics of fluconazole after a single intravenous dose in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Chromatography, High Pressure Liquid; Creatinine; Female; | 1994 |
Pharmacokinetics and bioavailability of fluconazole in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Biological Availability; Female; Fl | 1993 |
Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1995 |
Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections. Multicentre European Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents | 1997 |
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
Combining mortality and longitudinal measures in clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candi | 1999 |
Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Double-Blind Method; Esophagitis; Esophagosc | 1992 |
Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Cryptococcosis; Double-Blind Met | 1992 |
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Female; Fluconazole | 1992 |
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Female; Fluconazole | 1992 |
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Female; Fluconazole | 1992 |
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Female; Fluconazole | 1992 |
[Secondary prevention of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Esophageal Diseases; Female; Fluconazole; Fo | 1992 |
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Amphotericin B; Female; Fluco | 1992 |
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Amphotericin B; Female; Fluco | 1992 |
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Amphotericin B; Female; Fluco | 1992 |
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Amphotericin B; Female; Fluco | 1992 |
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Amphotericin B; Female; Fluco | 1992 |
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Amphotericin B; Female; Fluco | 1992 |
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Amphotericin B; Female; Fluco | 1992 |
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Amphotericin B; Female; Fluco | 1992 |
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Amphotericin B; Female; Fluco | 1992 |
Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidi | 1991 |
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Chronic Disease; Drug Administration Schedule | 1991 |
Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Alanine Transaminase; Asparta | 1991 |
Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Esophagitis; Female; Fluconazole; Humans; Ma | 1991 |
A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Cryptococcosis; Double-Blind Method; Drug Evaluatio | 1991 |
Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candidiasis, Oral; Clotrimazole; Fl | 1990 |
Fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antifungal Agents; Candidiasis; Clinical Trials as Topi | 1990 |
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1990 |
Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Candidiasis, Oral; Clinical Trials | 1990 |
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidi | 1989 |
Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Antifungal Agents; | 1988 |
167 other studies available for fluconazole and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Pharmacokinetics of fluconazole and ganciclovir as combination antimicrobial chemotherapy on ECMO: a case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Antiviral Agents; Candida albicans; Ca | 2021 |
Cryptococcal meningitis in patients with and without acquired immunodeficiency.
Topics: Acquired Immunodeficiency Syndrome; Fluconazole; Humans; Meningitis, Cryptococcal | 2022 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Diagnostic and management considerations in the modern patient with AIDS: a case of concurrent disseminated Kaposi sarcoma and colesional
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiretroviral The | 2020 |
Case Report: A Case of Severe Cryptococcal Immune Reconstitution Inflammatory Syndrome Presenting with Brain and Intradural Abscesses in an HIV Patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Inflammatory Agents; Anti-Retroviral Agents | 2020 |
An Iris Tumor Secondary to
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Fluconazole; Humans; Iris Neoplasms; M | 2022 |
Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoforman | 2017 |
Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Antigens, Fungal; Brazil; Cryptococcus | 2019 |
[Non-neuromeningeal cryptococcosis in patients with AIDS in Bamako, Mali: 2 case reports].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2014 |
Clinical presentation and diagnosis of toxoplasmic encephalitis in Japan.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Antiprotozoal Agents; Brain; Central N | 2014 |
Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease.
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Amyloid beta-Protein Precursor; Animals; | 2014 |
Antifungal Susceptibility Testing in HIV/AIDS Patients: a Comparison Between Automated Machine and Manual Method.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Mi | 2016 |
Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Crypto | 2017 |
Pleural effusion in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Male; Mi | 2008 |
Treatment of cryptococcal meningitis in Peruvian AIDS patients using amphotericin B and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Blood; Cerebrospinal F | 2008 |
Severe cutaneous adverse drug reaction due to fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Biopsy; Candidiasis, Oral; Diagnosis, | 2008 |
Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV | 2009 |
Coccidioidal meningitis and brain abscesses: analysis of 71 cases at a referral center.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Arizona; Brain Abscess; Coccidioides; Coccidi | 2009 |
Explosive nasofacial cryptococosis.
Topics: Acids; Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; An | 2010 |
Genotyping of fluconazole-resistant Candida albicans isolated from Uighurian people in Xinjing (China) using ALTS/RFLP and micro-TGGE method.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida albicans; China; Denaturing Gradient | 2010 |
Coccidioidal meningitis: clinical presentation and management in the fluconazole era.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin | 2010 |
Safety, censoring, and intent-to-treat analysis: dangers to generalizability.
Topics: Acquired Immunodeficiency Syndrome; Africa South of the Sahara; Alanine Transaminase; Anti-HIV Agent | 2010 |
Disseminated cryptococcosis and fluconazole resistant oral candidiasis in a patient with acquired immunodeficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Body Fluids; Candida tropicalis; Candi | 2010 |
Hoarseness of voice in an AIDS patient: a rare presenting feature of disseminated histoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antifungal Agents; Fluconazole; Histoplasm | 2011 |
A novel method of desensitization for fluconazole hypersensitivity in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 2011 |
Osteomyelitis as a manifestation of perinatal Human Immunodeficiency Virus disease.
Topics: Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; Antifungal Agents; Candida albicans; Can | 2011 |
[Neuromeningeal cryptococcosis and AIDS: an 11-case series from Libreville, Gabon].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; H | 2010 |
A retrospective study of AIDS-associated cryptomeningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Distribution; AIDS-Related Opportunistic Infections; | 2012 |
Pseudomembranous candidiasis in HIV/AIDS patients in Cali, Colombia.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Oral | 2013 |
Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Antiretroviral Therapy, Highly Active; | 2002 |
[A clinical study of 26 cases of cryptococcal meningitis].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Amphotericin B; Child; Cryptococcus; Drainage | 2002 |
Disseminated cryptococcosis in an AIDS patient caused by a canavanine-resistant strain of Cryptococcus neoformans var. grubii.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 2003 |
[Infection due to herpes zoster and cryptococcus after initiating high-activity antiretroviral treatment].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 2003 |
Fluconazole-resistant cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoforman | 2003 |
G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amino Acid Sequence; Amino Acid Substitution; Antifungal | 2003 |
Primary adrenal insufficiency in patients with acquired immunodeficiency syndrome: report of four cases.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Insufficiency; Adult; Antifungal Agents; Fluconazole; Hu | 2004 |
Successful discontinuation of high-dose fluconazole for Histoplasma capsulatum meningitis in an AIDS patient after sustained immune reconstitution.
Topics: Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; Antifungal Agents; CD4 Lymphocyte Count; | 2004 |
[Long QT and torsade de pointes in a patient with acquired human immunodeficiency virus infection in multitherapy with drugs affecting cytochrome P450].
Topics: Acquired Immunodeficiency Syndrome; Analgesics, Opioid; Antifungal Agents; Antiretroviral Therapy, H | 2004 |
The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Dr | 2005 |
Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amino Acid Substitution; | 2006 |
Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; | 2006 |
Management of cryptococcal meningitis in AIDS: the need for specific studies in developing countries.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Biomedical Research; Cryp | 2007 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Severe Candida krusei infection in an AIDS patient receiving long-term treatment with fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Fluconazole; Humans; Male; Middle Aged | 1995 |
Cryptococcosis, AIDS, and clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Drug Resistance; Drug Therapy, C | 1995 |
Disseminated histoplasmosis: successful maintenance therapy with oral fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Australia; El Salvador; Female; Flu | 1995 |
[Fungemia caused by Candida krusei in a female patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida; Candidiasis, Oral; Female; Fluco | 1994 |
Fungemia due to fluconazole-resistant Candida albicans in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candida albicans; Candidiasis; Drug | 1994 |
Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amphotericin B; Candidiasis, Oral; | 1994 |
Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis.
Topics: Acquired Immunodeficiency Syndrome; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole | 1994 |
Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Candida albicans; Candidiasis, Oral; DNA, Fungal; Drug Resistanc | 1994 |
Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candidiasis; Drug Administration Sc | 1994 |
Gastrointestinal histoplasmosis presenting as hematochezia in human immunodeficiency virus-infected hemophilic patients.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Diagnosis, Differential; Fluconazole; Gastrointe | 1994 |
HIV-negative "AIDS" in Kentucky: a case of idiopathic CD4+ lymphopenia and cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4 Antigens; Fluconazole; HIV Seronegativity; Humans; Ke | 1994 |
The natural history of esophageal candidiasis after successful treatment in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Candidiasis; Esophageal Diseases; Fluc | 1994 |
Persistence of initial infection in recurrent Cryptococcus neoformans meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Blotting, Southern; Cerebrospinal Fluid; Diagnosis, | 1993 |
Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; AIDS-Related Opportunistic Infections; CD4-P | 1993 |
[Esophageal mycosis during primary human immunodeficiency virus infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Fluco | 1993 |
[Resistance of Candida sp. to fluconazole in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Fluconaz | 1993 |
Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group.
Topics: Acquired Immunodeficiency Syndrome; Agar; Candida albicans; Candidiasis; Culture Media; Drug Resista | 1993 |
Successful treatment of disseminated cryptococcosis with high-dose oral fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cryptococcosis; Fluconazole; Humans; Male | 1993 |
Acute meningitis from Cryptococcus neoformans (Filobasidiella neoformans) in a patient suffering from AIDS. Report of a clinical case with a favourable outcome.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Cerebrospinal Fluid; Comorbidity; Cryptoco | 1993 |
Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Animals; Disease Models, Animal; Drug Resistance, Microbial; Flu | 1993 |
Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chagas Disease; Dr | 1993 |
Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; His | 1993 |
Trichosporon beigelii fungaemia in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Female; Fluconazol | 1993 |
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alleles; Antifungal Agents; Candida albicans; Candidiasis | 1995 |
Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1996 |
Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antifungal Agents; Candida albicans; Candidiasis, Oral; | 1996 |
Fluconazole plus allopurinol in treatment of visceral leishmaniasis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Allopurinol; Antifungal Agents; Antimetabolites; Bone Mar | 1996 |
Inflammatory opacities of the vitreous in rifabutin-associated uveitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Eye Diseases; Female; Fluconazole; | 1996 |
Serum cryptococcal antigen in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Animals; Antifungal Agents; Antigens, Fungal; CD | 1996 |
Isolated detection of cryptococcal polysaccharide antigen in cerebrospinal fluid samples from patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Antigens, Fungal; CD4 Lymphocyte Count | 1996 |
Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida; Candidiasis, Oral; CD4 Lymphocyte Co | 1997 |
Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Candida albicans; Drug | 1997 |
Idiopathic midesophageal stricture: a new cause of dysphagia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy; Candidiasis; Deglutition Disorders; Esophageal St | 1997 |
Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combinat | 1996 |
Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
Topics: 17-Hydroxycorticosteroids; Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections | 1997 |
Successful use of boric acid to control azole-refractory Candida vaginitis in a woman with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Intravaginal; Adult; Antifungal Agents; Boric Ac | 1997 |
Neutrophil phagocytosis in AIDS patients with azole resistant candidiasis.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles | 1997 |
Variation in morphotype, karyotype and DNA type of fluconazole resistant Candida albicans from an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Candid | 1998 |
Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Cryptococcosis; Cryptococ | 1998 |
In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; | 1998 |
Case report of long-term survival in a patient with acquired immunodeficiency syndrome and cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; An | 1998 |
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasi | 1998 |
Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cluster Analysis; Cryptococcus neoformans; DN | 1998 |
Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antifungal Agents; Azoles; Brazil; Candida albicans | 1998 |
Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Cells, Cultured; Cryptococcus neoforma | 1999 |
HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Inflammatory Agents; Cryptococcosis; Fluconazole; HI | 1998 |
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoforman | 1999 |
Disseminated cutaneous sporotrichosis in an AIDS patient receiving maintenance therapy with fluconazole for previous cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Female; Fluconazole; Humans; Meningitis, | 1999 |
In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus | 2000 |
Rapid detection of point mutations by fluorescence resonance energy transfer and probe melting curves in Candida species.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida; DNA, Fungal; Electrophoresis, Agar G | 2000 |
Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; | 2000 |
Granulomatous amebic encephalitis in a patient with AIDS: isolation of acanthamoeba sp. Group II from brain tissue and successful treatment with sulfadiazine and fluconazole.
Topics: Acanthamoeba; Acquired Immunodeficiency Syndrome; Adult; Amebiasis; Animals; Antibiotic Prophylaxis; | 2000 |
AIDS activists force attention to fluconazole in South Africa.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Ind | 2000 |
AIDS and Africa.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Africa; AIDS Vaccines; Anti-HIV Agents; Antif | 2000 |
South Africa cuts agreement for one AIDS drug but ignores another.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Cost Savings; Drug Indust | 2001 |
Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B | 2001 |
Pfizer offers fluconazole to some AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Drug Industry; Fluconazole; Humans; Mycoses | 2001 |
Resistant mechanisms of Candida albicans to fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistanc | 1999 |
Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Diseas | 2001 |
Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Antige | 2002 |
"In vitro" antifungal activity of protease inhibitors.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Candid | 2001 |
A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Antige | 2002 |
Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; An | 2002 |
[Pulmonary cryptococcosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cr | 1992 |
Fluconazole antifungal agent.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Child, Preschool; Drug Interactions; Flucona | 1992 |
Porphyria cutanea tarda in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Fluconazole; Humans; Male; Middle Aged; Porphyria Cutane | 1992 |
[Treatment and secondary prophylaxis with fluconazole for oropharyngeal candidiasis in HIV-positive patients. A mycological analysis of failures].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Candida albicans; Candidiasis, Oral; Female; | 1992 |
Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Fluconazole; Humans; Meningitis, Cryptococcal | 1992 |
Cryptococcal meningitis in AIDS occurring despite systemic antifungal therapy.
Topics: Acquired Immunodeficiency Syndrome; Fluconazole; Humans; Ketoconazole; Meningitis, Cryptococcal | 1992 |
Rapid relapse of cryptococcal meningitis after termination of maintenance fluconazole in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cryptococcus neoformans; Fluconazole; Follow-Up Studies; | 1992 |
[Cryptococcosis and acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Cryptococcosis; Fluconazole; Humans; Prognosis | 1992 |
Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatment with fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Drug Evaluation; Female; Fluconazole; Humans; Male; Meningitis, | 1992 |
[Cryptococcal meningitis in patients with AIDS: combined treatment with amphotericin B and fluconazole, and high levels of adenosine deaminase in cerebrospinal fluid].
Topics: Acquired Immunodeficiency Syndrome; Adenosine Deaminase; Adult; Amphotericin B; Drug Therapy, Combin | 1992 |
Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Fluconazole; Humans; Male; Meningit | 1992 |
[Cryptococcosis in AIDS patients: a study of 19 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; | 1992 |
[Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes].
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Drug Administration Schedule; Esophageal Dis | 1992 |
Suppressive therapy for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Fluconazole; Humans; Meningitis, Cryptococcal; R | 1992 |
Yeasts susceptibility testing.
Topics: Acquired Immunodeficiency Syndrome; Candida albicans; Candidiasis, Oral; Fluconazole; Humans; Microb | 1991 |
Fluconazole resistant candida in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazol | 1991 |
[Cryptococcal meningitis in AIDS: successful long-term prophylaxis with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antigens, Bacterial; Cryptococcus; Drug T | 1991 |
Fluconazole-associated acute adrenal insufficiency.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adrenal Insufficiency; Adult; Fluconazole; Humans | 1991 |
Fluconazole resistance in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fl | 1991 |
[Resistance to fluconazole in hospitalized patients. Concordance between Candida albicans resistance in vitro and therapeutic failure].
Topics: Acquired Immunodeficiency Syndrome; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; | 1991 |
Fluconazole well tolerated by AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Fluconazole; Humans; Male; Meningitis, Cryptococcal | 1991 |
Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Confidence Intervals; Cryptococcosis; Fluconazol | 1991 |
[Laboratory's controls of antifungal treatment by the fluconazole of the candidiasis in immunocompromised patients].
Topics: Acquired Immunodeficiency Syndrome; Candida albicans; Candidiasis; Dose-Response Relationship, Drug; | 1991 |
Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amphotericin B; Costs and Cost Analysis; C | 1991 |
Failure of ketoconazole maintenance therapy for disseminated coccidioidomycosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Coccidioidomycosis; Fluconazole; Humans; Ketoconazole; Ma | 1991 |
Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Administration, Oral; Adult; Amphotericin B; Antifung | 1991 |
Successfully treated candida sinusitis in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Empyema, Subdural; Ethmoid Sinusitis; Flucon | 1990 |
Clinical aspects of HIV and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Fluconazole; Ganciclovir; HIV Infections; Humans; Opportunistic | 1990 |
Treatment of refractory oral candidiasis with fluconazole. A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida albicans; Candidiasis, Oral; Clot | 1991 |
Profound papilledema due to cryptococcal meningitis in acquired immunodeficiency syndrome: successful treatment with fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Cryptococcosis; Fluconazole; Humans; Male | 1991 |
Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Fluconazole; Humans; Liver; Male | 1991 |
Fluconazole resistant candida in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazol | 1991 |
Candida albicans resistance in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal | 1991 |
[Antimycotic agents selectively damages the fungus membrane. AIDS patients--cryptococcosis--oropharyngeal candidiasis].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans | 1991 |
[Meningitis caused by Candida albicans in a patient with AIDS. Treatment with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis; Fluconazole; Humans; Male; Meningitis | 1990 |
[The therapy of Candida esophagitis in AIDS patients with fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Esophagitis; Esophagoscopy; Fluconazole; Humans; Op | 1990 |
Rhinophyma-like cryptococcal infection as an early manifestation of AIDS in a hemophilia B patient.
Topics: Acquired Immunodeficiency Syndrome; Cryptococcosis; Diagnosis, Differential; Fluconazole; Hemophilia | 1990 |
Infectious disease emergencies in persons with HIV/AIDS: an update.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Clindamycin; Communicable Diseases; Fluconazole; | 1990 |
Interaction between fluconazole and rifampicin.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cryptococcosis; Drug Interactions; Fluconazole; Humans; M | 1990 |
Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Candida; Cryptococcus neoformans; Fluconazole; H | 1990 |
From the Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Drug Labeling; Fluconazole; Humans; Mycoses; Patient Education a | 1990 |
AIDS file. New oral antifungal may replace i.v. treatment.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Candidiasis, Oral; Fluconazole; Humans; Op | 1990 |
Fluconazole approved for AIDS complications.
Topics: Acquired Immunodeficiency Syndrome; Fluconazole; Humans; Opportunistic Infections | 1990 |
High dose oral fluconazole for oropharyngeal candidosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Candidiasis, Oral; Fluconazole; Humans; Ma | 1990 |
Fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Animals; Aspergillosis; Candidiasis, Chronic Mucocutaneous; Cryp | 1990 |
Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cryptococcus; Fluconazole; Half-Life; Humans; Injections, | 1990 |
Fluconazole for cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Meningit | 1989 |
Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Pilot | 1989 |
[AIDS: bad prognosis in candidiasis. Cryptococcosis in brain involvement is usually fatal--experiences with a new therapeutic drug].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningit | 1989 |
[Clinical evaluation of fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Ambulatory Care; Antifungal Agents; Antigens, Funga | 1989 |
[AIDS fungus infections. Fluconazole--a new preparation in development].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Fluconazol | 1989 |
Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus | 1989 |
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Di | 1989 |
Fluconazole treatment of cryptococcosis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Triazole | 1989 |
[Value of fluconazole in the treatment of systemic yeast infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Candidiasis; Cryptococcosis; Female; Fluconazole; H | 1989 |
Disseminated histoplasmosis in a Danish patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Denmark; Fluconazole; Histiocytes; Histop | 1989 |
Fluconazole versus ketoconazole in oropharyngeal candidiasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Female; Fluconazole; Humans; Ketoconazole; Ma | 1989 |
Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Flucon | 1988 |
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Antifungal Agents; Anti | 1988 |
Fluconazole for the treatment of fungal diseases in immunosuppressed patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Candidiasis, Oral; Cryptococcosis; Flu | 1988 |
Cryptococcal meningitis and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; M | 1987 |